SOX11 and mantle cell lymphoma: The WHO has principally divided MCL into two categories: conventional MCL, with expression of SOX11, unmutated IGHV, and an aggressive course; and leukemic non-nodal MCL, characterized by mutated IGHV, lack of SOX11, and indolent clinical course [52].